Captrust Financial Advisors Increases Stake in ResMed Inc.

The investment firm added 27,565 shares of the medical equipment provider during the third quarter.

Mar. 18, 2026 at 8:36am

Got story updates? Submit your updates here. ›

Captrust Financial Advisors, an investment management firm, increased its stake in ResMed Inc. (NYSE:RMD) by 5.4% during the third quarter of 2026. The firm now owns 537,623 shares of the medical equipment provider's stock, worth approximately $147 million.

Why it matters

ResMed is a leading manufacturer of medical devices for the treatment of sleep-disordered breathing and other respiratory conditions. Captrust's increased investment in the company suggests the firm sees long-term growth potential in ResMed's products and market position.

The details

According to a recent 13F filing with the SEC, Captrust Financial Advisors purchased an additional 27,565 shares of ResMed during the third quarter. This brings the firm's total ownership stake in ResMed to approximately 0.37% of the company's outstanding shares.

  • Captrust Financial Advisors increased its ResMed holdings during the third quarter of 2026.

The players

Captrust Financial Advisors

An investment management firm that provides wealth management, investment advisory, and retirement plan services.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

Captrust's increased stake in ResMed suggests the firm sees long-term growth potential in the medical device company, which is a leader in the sleep apnea and respiratory treatment market.